Whalatane
Yes, exactly and I was interested in how soon it would be approved in the USA! I liked the summary analysis from the Needham analyst, Mike Matson, too & hopefully he is a well respected person; however his price objective seems very low to me.
Do you feel that we will see something soon from CMS? You mentioned that they seemed favorably inclined to approve fairly soon. The higher code price of $4000 to $5000 is surely a problem.
Bottomline: if CMS approves a price target of $283 seems modest to me
PS I'm glad I have another person following things & and normally I am put off on insider selling, but who can blame them as long as they maintain a sizable core holding
Market Data 
Markets 
AI
